how overall survival and primary causes of death have changed in patients with al amyloidosis
Published 2 years ago • 592 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:09
how patient outcomes in al amyloidosis have changed following the use of bortezomib-based therapy
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
1:03
real-world management of patients with al amyloidosis
-
13:05
pro tips for sharpening survival knives
-
3:56
how to survive being stranded in the outback, according to science
-
11:12
challenge to origin of life: biopolymers (long story short, ep. 5)
-
5:16
the evolution of al amyloidosis therapy
-
2:11
selecting patients with al amyloidosis for autohsct
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
1:35
vital results for birtamimab in al amyloidosis
-
1:29
the impact of clonal features on the survival of patients with non-cardiac al amyloidosis
-
2:13
advances & unanswered questions about the role of mrd in al amyloidosis
-
1:45
real-world data in guiding amyloidosis treatment
-
2:45
burning questions: asct in al amyloidosis
-
4:32
overall survival in patients with chl who progress after autosct in the era of novel agents
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
2:00
al amyloidosis: hot topics from isa 2020
-
1:04
aa amyloidosis management
-
0:52
tocilizumab for aa amyloidosis
-
2:23
the use of solid organ transplant in al amyloidosis